Wednesday, February 18


Bengaluru: Medtronic surpassed Wall Street expectations ​for third-quarter profit and revenue on Tuesday, buoyed by ​strong demand for its heart devices.

But shares of the company were down 2.9% in premarket trading after it maintained its fiscal 2026 adjusted per share profit ‌forecast at $5.62 ⁠to $5.66.

J.P. Morgan ⁠analyst Robbie Marcus said he expects “to see some scrutiny,” as the outlook was ​reiterated despite the quarterly beat and an around 100-basis-point benefit from foreign exchange, adding ​that this implies lower underlying growth for the fourth quarter.

Medtronic’s growth drivers include its pulsed field ablation systems and its transcatheter aortic valve replacement devices, two minimally invasive technologies for ⁠heart conditions ‌that are seeing rapid adoption.

Sales in the company’s cardiovascular ​segment, which accounts ​for nearly 40% of sales, jumped 13.8% to $3.46 ⁠billion during the quarter, powered by strong demand for ​its pulsed field ablation portfolio.

The technology uses high-energy electric ​pulses to destroy targeted heart tissues to reduce the frequency of abnormal heart rhythms.

Medtech firms are benefiting from surging demand for medical procedures as health insurers report higher medical loss ratios – an indication that patients are availing more procedures. Market optimism is also boosted by ‌wider physician uptake and technological advances.

Revenue for the third quarter came in at $9.02 billion, beating analysts’ average estimate of $8.91 ​billion, according to ​data compiled by ⁠LSEG.

Sales in the company’s neuroscience segment, which makes spinal implants and software, rose 4.1% to $2.56 billion, but missed estimates of $2.59 billion.

On an adjusted basis, ​the company reported quarterly profit of $1.36 per share, above estimates of $1.33 per share.

Larger peer Johnson & Johnson posted a 7.5% year-over-year increase in medtech sales in the reported quarter, driven by strength in its electrophysiology segment that includes its heart devices.

(Reporting by Padmanabhan Ananthan and Puyaan Singh in Bengaluru; Editing by Sahal Muhammed)

  • Published On Feb 18, 2026 at 07:37 AM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETHealthworld industry right on your smartphone!




Source link

Share.
Leave A Reply

Exit mobile version